Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription

Articles published in Int J Cardiol

Retrieve available abstracts of 54 articles:
HTML format

Single Articles

    May 2021
  1. OTTOSSON F, Emami Khoonsari P, Gerl MJ, Simons K, et al
    A plasma lipid signature predicts incident coronary artery disease.
    Int J Cardiol. 2021;331:249-254.
    PubMed     Abstract available

    January 2021
  2. NOURAEI H, Rabkin SW
    A new approach to the clinical subclassification of heart failure with preserved ejection fraction.
    Int J Cardiol. 2021 Jan 30. pii: S0167-5273(21)00134.
    PubMed     Abstract available

  3. HAN J, Bilgrami S, Ross S, Broadhead H, et al
    Real-world lipid lowering effects of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors: A single-centre study.
    Int J Cardiol. 2021;322:240-244.

    October 2020
  4. ATHYROS VG, Stavropoulos K, Imprialos KP, Doumas M, et al
    Suboptimal management of dyslipidemia in everyday clinical practice: Alarming signals from real-world data.
    Int J Cardiol. 2020;316:240-241.

    December 2019
  5. STEWART LK, Beam DM, Casciani T, Cameron SJ, et al
    Effect of metabolic syndrome on mean pulmonary arterial pressures in patients with acute pulmonary embolism treated with catheter-directed thrombolysis.
    Int J Cardiol. 2019 Dec 26. pii: S0167-5273(19)30431.
    PubMed     Abstract available

    November 2019
  6. BANDYOPADHYAY D, Chakraborty S, Amgai B, Patel N, et al
    Acute myocardial infarction in the young - National Trend Analysis with gender-based difference in outcomes.
    Int J Cardiol. 2019 Nov 12. pii: S0167-5273(19)33095.
    PubMed     Abstract available

    September 2019
  7. PRESTA V, Tocci G, Volpe M
    Excess of dyslipidemia in low income countries: The case of Colombia in the PURE study.
    Int J Cardiol. 2019;290:152-153.

    August 2019
  8. DAGHISTANI TA, Elshawi R, Sakr S, Ahmed AM, et al
    Predictors of in-hospital length of stay among cardiac patients: A machine learning approach.
    Int J Cardiol. 2019;288:140-147.
    PubMed     Abstract available

    July 2019
  9. CIFKOVA R, Pitha J, Krajcoviechova A, Kralikova E, et al
    Is the impact of conventional risk factors the same in men and women? Plea for a more gender-specific approach.
    Int J Cardiol. 2019;286:214-219.
    PubMed     Abstract available

    June 2019
  10. KWON S, Lee SR, Choi EK, Lee SH, et al
    Visit-to-visit variability of metabolic parameters and risk of heart failure: A nationwide population-based study.
    Int J Cardiol. 2019 Jun 20. pii: S0167-5273(19)32002.
    PubMed     Abstract available

  11. CAMACHO PA, Otero J, Perez M, Arcos E, et al
    The spectrum of the dyslipidemia in Colombia: The PURE study.
    Int J Cardiol. 2019;284:111-117.
    PubMed     Abstract available

  12. HAMIEH N, Meneton P, Wiernik E, Limosin F, et al
    Depression, treatable cardiovascular risk factors and incident cardiac events in the Gazel cohort.
    Int J Cardiol. 2019;284:90-95.
    PubMed     Abstract available

    March 2019
  13. IZQUIERDO GONZALEZ R, Dorrego Garcia RM, Rodriguez Ledo P, Segura Heras JV, et al
    Screening based on risk factors for abdominal aortic aneurysm in the cardiology clinic.
    Int J Cardiol. 2019;279:162-167.
    PubMed     Abstract available

    February 2019
  14. MAZIDI M, Mikhailidis DP, Banach M
    Associations between risk of overall mortality, cause-specific mortality and level of inflammatory factors with extremely low and high high-density lipoprotein cholesterol levels among American adults.
    Int J Cardiol. 2019;276:242-247.
    PubMed     Abstract available

    January 2019
  15. WANG Z, Wang X, Hao G, Chen Z, et al
    A national study of the prevalence and risk factors associated with peripheral arterial disease from China: The China Hypertension Survey, 2012-2015.
    Int J Cardiol. 2019;275:165-170.
    PubMed     Abstract available

    November 2018
  16. WANG H, Sun Y
    Further insight into the impact of the NLA guideline, ESC guideline, and AACE/ACE guideline on LDL-cholesterol target achievement: Time to rethink the strategy?
    Int J Cardiol. 2018;271:347.

    October 2018
    Impact of statin-ezetimibe combination in chronic kidney disease.
    Int J Cardiol. 2018;268:36-37.

  18. BREUKER C, Clement F, Mura T, Macioce V, et al
    Non-achievement of LDL-cholesterol targets in patients with diabetes at very-high cardiovascular risk receiving statin treatment: Incidence and risk factors.
    Int J Cardiol. 2018;268:195-199.
    PubMed     Abstract available

    September 2018
  19. KUMAR R, Tonkin A, Liew D, Zomer E, et al
    The cost-effectiveness of PCSK9 inhibitors - The Australian healthcare perspective.
    Int J Cardiol. 2018;267:183-187.
    PubMed     Abstract available

  20. WON KB, Han D, Lee JH, Lee SE, et al
    Impact of optimal glycemic control on the progression of coronary artery calcification in asymptomatic patients with diabetes.
    Int J Cardiol. 2018;266:250-253.
    PubMed     Abstract available

    August 2018
  21. YAN BP, Chiang FT, Ambegaonkar B, Brudi P, et al
    Low-density lipoprotein cholesterol target achievement in patients surviving an acute coronary syndrome in Hong Kong and Taiwan - findings from the Dyslipidemia International Study II.
    Int J Cardiol. 2018;265:1-5.
    PubMed     Abstract available

  22. BECKOWSKI M, Gierlotka M, Gasior M, Polonski L, et al
    Risk factors predisposing to acute coronary syndromes in young women </=45years of age.
    Int J Cardiol. 2018;264:165-169.
    PubMed     Abstract available

    July 2018
  23. LIBERALE L, Carbone F, Bertolotto M, Bonaventura A, et al
    Serum PCSK9 levels predict the occurrence of acute coronary syndromes in patients with severe carotid artery stenosis.
    Int J Cardiol. 2018;263:138-141.
    PubMed     Abstract available

    June 2018
  24. HERMANN M, Witassek F, Erne P, Radovanovic D, et al
    Referral for cardiac rehabilitation after acute myocardial infarction: Insights from nationwide AMIS Plus registry 2005-2017.
    Int J Cardiol. 2018;261:1-5.
    PubMed     Abstract available

  25. KUWABARA M, Borghi C, Cicero AFG, Hisatome I, et al
    Elevated serum uric acid increases risks for developing high LDL cholesterol and hypertriglyceridemia: A five-year cohort study in Japan.
    Int J Cardiol. 2018;261:183-188.
    PubMed     Abstract available

  26. WANG X, Fu Q, Song F, Li W, et al
    Prevalence of atrial fibrillation in different socioeconomic regions of China and its association with stroke: Results from a national stroke screening survey.
    Int J Cardiol. 2018 Jun 2. pii: S0167-5273(18)30996.
    PubMed     Abstract available

  27. ZHANG M, Deng Q, Wang L, Huang Z, et al
    Prevalence of dyslipidemia and achievement of low-density lipoprotein cholesterol targets in Chinese adults: A nationally representative survey of 163,641 adults.
    Int J Cardiol. 2018;260:196-203.
    PubMed     Abstract available

    May 2018
  28. SHIN D, Kongpakpaisarn K, Bohra C
    Trends in the prevalence of metabolic syndrome and its components in the United States 2007-2014.
    Int J Cardiol. 2018;259:216-219.
    PubMed     Abstract available

    March 2018
  29. FREISINGER E, Malyar NM, Reinecke H, Unrath M, et al
    Low rate of revascularization procedures and poor prognosis particularly in male patients with peripheral artery disease - A propensity score matched analysis.
    Int J Cardiol. 2018;255:188-194.
    PubMed     Abstract available

  30. CANEPA M, Artom N, Ameri P, Carbone F, et al
    Short-term effect of rosuvastatin treatment on arterial stiffness in individuals with newly-diagnosed heterozygous familial hypercholesterolemia.
    Int J Cardiol. 2018;255:215-220.

  31. MACHADO LBM, Silva BLS, Garcia AP, Oliveira RAM, et al
    Ideal cardiovascular health score at the ELSA-Brasil baseline and its association with sociodemographic characteristics.
    Int J Cardiol. 2018;254:333-337.
    PubMed     Abstract available

  32. FEDELI U, Avossa F, Ferroni E, Schievano E, et al
    Diverging patterns of cardiovascular diseases across immigrant groups in Northern Italy.
    Int J Cardiol. 2018;254:362-367.
    PubMed     Abstract available

    February 2018
  33. GUPTA R, Singh Y
    Treatment gaps in severe hypercholesterolemia.
    Int J Cardiol. 2018;252:199-200.

  34. FAGGIANO P, Pirillo A, Griffo R, Ambrosetti M, et al
    Prevalence and management of familial hypercholesterolemia in patients with coronary artery disease: The heredity survey.
    Int J Cardiol. 2018;252:193-198.
    PubMed     Abstract available

    November 2017
  35. LIN XL, Liu MH
    Statin and ezetimibe combination therapy: New therapeutic options for lowering Low-Density Lipoprotein Cholesterol.
    Int J Cardiol. 2017;247:49.

    March 2017
  36. LEE H, Choi EK, Lee SH, Han KD, et al
    Atrial fibrillation risk in metabolically healthy obesity: A nationwide population-based study.
    Int J Cardiol. 2017 Mar 28. pii: S0167-5273(16)32706.
    PubMed     Abstract available

    February 2017
  37. DUFOUR R, Bergeron J, Gaudet D, Weiss R, et al
    Open-label therapy with alirocumab in patients with heterozygous familial hypercholesterolemia: Results from three years of treatment.
    Int J Cardiol. 2017;228:754-760.
    PubMed     Abstract available

    January 2017
  38. LIN PY, Lee FY, Wallace CG, Chen KH, et al
    The therapeutic effect of rosuvastatin and propylthiouracil on ameliorating high-cholesterol diet-induced rabbit aortic atherosclerosis and stiffness.
    Int J Cardiol. 2017;227:938-949.
    PubMed     Abstract available

  39. HU D, Yang Y, Peng DQ
    Increased sortilin and its independent effect on circulating proprotein convertase subtilisin/kexin type 9 (PCSK9) in statin-naive patients with coronary artery disease.
    Int J Cardiol. 2017;227:61-65.
    PubMed     Abstract available

  40. KISHIMOTO S, Kajikawa M, Maruhashi T, Iwamoto Y, et al
    Endothelial dysfunction and abnormal vascular structure are simultaneously present in patients with heart failure with preserved ejection fraction.
    Int J Cardiol. 2017 Jan 5. pii: S0167-5273(16)32405.
    PubMed     Abstract available

    November 2016
  41. KUWABARA M, Niwa K, Nishihara S, Nishi Y, et al
    Hyperuricemia is an independent competing risk factor for atrial fibrillation.
    Int J Cardiol. 2016 Nov 15. pii: S0167-5273(16)32841.
    PubMed     Abstract available

    August 2016
  42. BAEK YS, Yang PS, Kim TH, Uhm JS, et al
    Delayed recurrence of atrial fibrillation 2years after catheter ablation is associated with metabolic syndrome.
    Int J Cardiol. 2016;223:276-281.
    PubMed     Abstract available

  43. REYES EB, Ha JW, Firdaus I, Ghazi AM, et al
    Heart failure across Asia: Same healthcare burden but differences in organization of care.
    Int J Cardiol. 2016;223:163-167.
    PubMed     Abstract available

    July 2016
  44. MENDEZ-BAILON M, Munoz-Rivas N, Jimenez-Garcia R, Esteban-Hernandez J, et al
    Impact of type 2 diabetes mellitus in hospitalizations for atrial fibrillation in Spain (2004-2013).
    Int J Cardiol. 2016;221:688-694.
    PubMed     Abstract available

    June 2016
  45. SAHINER L, Asil S, Kaya EB, Ozer N, et al
    Percutaneous Implantation of the self-expanding valve Prosthesis a patient with homozygous familial hypercholesterolemia severe aortic stenosis and porcelain aorta.
    Int J Cardiol. 2016;220:661-664.
    PubMed     Abstract available

  46. XIA SJ, Du X, Li C, Wu JH, et al
    Uptake of evidence-based statin therapy among atrial fibrillation patients in China: A report from the CAFR (Chinese Atrial Fibrillation Registry) Study.
    Int J Cardiol. 2016;220:284-289.
    PubMed     Abstract available

  47. WU AH, Gladden JD, Ahmed M, Ahmed A, et al
    Relation of serum uric acid to cardiovascular disease.
    Int J Cardiol. 2016;213:4-7.
    PubMed     Abstract available

    May 2016
  48. PLAKHT Y, Gilutz H, Shiyovich A
    Decreased admission serum albumin level is an independent predictor of long-term mortality in hospital survivors of acute myocardial infarction. Soroka Acute Myocardial Infarction II (SAMI-II) project.
    Int J Cardiol. 2016;219:20-24.
    PubMed     Abstract available

    April 2016
  49. DI MINNO MN, Di Minno A, Ambrosino P, Songia P, et al
    Aortic valve sclerosis as a marker of atherosclerosis: Novel insights from hepatic steatosis.
    Int J Cardiol. 2016;217:1-6.
    PubMed     Abstract available

    March 2016
  50. MASCITELLI L, Goldstein MR
    Might ezetimibe be considered an expensive placebo?
    Int J Cardiol. 2016;207:48-9.

    January 2016
  51. NAKOU ES, Simantirakis EN, Kallergis EM, Skalidis EI, et al
    Long-standing sinus arrest due to the occlusion of sinus node artery during percutaneous coronary intervention: Clinical implications and management.
    Int J Cardiol. 2016;203:432-3.

  52. TANG L, Jiang L, Pan XD, Chen PP, et al
    Extremely severe aortic stenosis developed in a young female patient with underdiagnosis of homozygous familial hypercholesterolemia: An 8-year follow-up.
    Int J Cardiol. 2016;207:372-374.

  53. ZU L, Ren C, Pan B, Zhou B, et al
    Endothelial microparticles after antihypertensive and lipid-lowering therapy inhibit the adhesion of monocytes to endothelial cells.
    Int J Cardiol. 2016;202:756-9.

  54. OIKONOMOU E, Siasos G, Tousoulis D
    Atherogenesis and hyperlipidemia a not straightforward association: We really need a novel biomarker?
    Int J Cardiol. 2016;202:586-8.

Thank you for your interest in scientific medicine.

AMEDEO Dyslipidemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.